Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement

Dec

05

Today In Oncology

Impact of Menopausal Status on Long-Term Benefit From Antihormonal Treatment in Women With Breast Cancer

Regional Racial Economic Disparities in Air Pollution Related Cancer Risk May Be Improving but Still Persist

Challenges and Potential of Mesenchymal Stem Cells in Cancer Immunotherapy

Lenvatinib-Pembrolizumab vs Chemotherapy in Advanced Endometrial Cancer

Toripalimab Plus Chemotherapy in First-Line Therapy for Extensive-Stage Small Cell Lung Cancer

Advertisement

© 2024 HSP News Service, L.L.C.